Cathy Burgess, Benjamin Wolf, Jong Ho "Philip" Won, Ph.D. The Food and Drug Administration’s (FDA) recent rejection of all study data from Mid-Link Testing highlights the importance of using reliable, ...
The FDA has eliminated a key barrier to the use of real-world evidence in certain medical device applications. Under new guidance issued Dec. 15, the agency said it will accept real-world evidence ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
Faster Medicare Coverage. The Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration ...
FDA has moved artificial intelligence (AI) in medical devices from an exploratory concept to operational expectations, finalizing a pathway to pre-approved algorithm updates (PCCPs), publishing ...
The FDA said it plans to accept new forms of real-world evidence in product applications, starting with a subset of medical device submissions. The agency said the policy change aims to enable the use ...
On January 6, 2024, FDA released draft guidance on Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations (the “draft guidance”). The ...
The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...
Echoing President Donald Trump’s call to accelerate medical innovation, Food and Drug Administration (FDA) Commissioner Marty Makary announced that the agency will no longer block companies from ...
In the second quarter of 2014, the U.S. Food and Drug Administration has issued eight draft and final guidance documents related to medical device manufacturers and marketers. Compiled by The National ...
Morning Overview on MSN
FDA clears first US trial of Motif’s wireless brain implant for depression
A coin-sized device with no battery, no wires, and no deep surgical penetration into the brain just cleared its biggest regulatory hurdle. In late April 2026, the FDA granted Motif Neurotech an ...
The FDA has granted pre-market approval to JenaValve’s Trilogy system, the first transcatheter aortic valve replacement (TAVR) device in the U.S. specifically indicated for severe aortic regurgitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results